Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Patients with prolonged effect of succinylcholine or mivacurium had novel mutations in the butyrylcholinesterase gene

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Re: The recent paper 'Genetic determinants of impaired awareness of hypoglycaemia in type 1 diabetes'

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The effects of inherited NUDT15 polymorphisms on thiopurine active metabolites in Japanese children with acute lymphoblastic leukemia

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Nomenclature for alleles of the human carboxylesterase 1 gene

    Research output: Contribution to journalComment/debateResearchpeer-review

  1. Deep neuromuscular blockade and surgical conditions during laparoscopic ventral hernia repair: A randomised, blinded study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Low concentrations of 25-hydroxyvitamin D and long-term prognosis of COPD: a prospective cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Validation of subjective rating scales for assessment of surgical workspace during laparoscopy

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

INTRODUCTION: Mutations in the butyrylcholinesterase enzyme (BChE) can result in prolonged duration of action of the neuromuscular blocking agents, succinylcholine and mivacurium, as BChE hydrolyses these drugs. Hereditary low BChE activity can cause extensively prolonged apnoea during general anaesthesia when these drugs are used. The aim of this study was to describe novel mutations in the butyrylcholinesterase gene (BCHE) in patients who have experienced prolonged duration of action of mivacurium or succinylcholine.

METHODS: The Danish Cholinesterase Research Unit registers patients with prolonged duration of action to succinylcholine and mivacurium. Patients were studied if they had equivocal phenotypes on the basis of BChE activity, biochemical inhibitor reactions and with pedigree if possible. Complete nucleotide sequencing was performed to describe the genotype and pedigree was used to separate the alleles. Multiple sequence alignment of BChE was performed for comparison with other species.

RESULTS: Genotyping indicated seven novel mutations in the BCHE (I373T, G467S, W518R, L184S, V421A, M462I and R577H).

CONCLUSION: We have found seven new variants of the BCHE, which seem to reduce the activity of BChE in patients undergoing anaesthesia involving succinylcholine or mivacurium.

Original languageEnglish
JournalPharmacogenetics and Genomics
Volume26
Issue number7
Pages (from-to)351-6
Number of pages6
ISSN1744-6872
DOIs
Publication statusPublished - Jul 2016

    Research areas

  • Journal Article

ID: 49819618